Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Operating activities:
Net income (loss)	$ 5,557	$ 29,650
Reconciliation of net income to net cash provided by operating activities:
Depreciation, amortization, and accretion	26,367	25,705
Impairments and other charges	109	777
(Gain) loss on investments	(3,591)	157
Equity-based compensation expense	4,904	4,199
(Recovery of) provision for credit losses	(37)	190
Amortization and expense of financing costs	1,123	2,707
Loss on debt extinguishment	5,535	0
Insurance recoveries associated with damaged equipment	0	(2,850)
Gain on sale of assets	(142)	(432)
Other non-cash charges (credits)	307	(1,721)
Changes in operating assets and liabilities:
Accounts receivable	3,009	7,600
Inventories	(1,958)	(19,990)
Prepaid expenses and other current assets	(1,230)	1,313
Trade accounts payable and accrued expenses	(5,884)	2,893
Other	(3,184)	1,133
Net cash provided by (used in) operating activities	30,885	51,331
Investing activities:
Purchases of property, plant, and equipment, net	(45,792)	(30,240)
Proceeds from sale of property, plant, and equipment	2,656	658
Proceeds from insurance recoveries associated with damaged equipment	0	2,850
Purchase of investments	(1,021)	(350)
Other investing activities	(287)	(1,836)
Net cash used in investing activities	(44,444)	(28,918)
Financing activities:
Proceeds from credit agreements and long-term debt	184,722	97,384
Principal payments on credit agreements and long-term debt	(163,481)	(98,441)
Payments on financing lease obligations	(1,054)	(837)
Debt issuance costs	(5,956)	0
Shares withheld for taxes on equity-based compensation	(2,953)	0
Other financing activities	(1,280)	0
Net cash provided by (used in) financing activities	9,998	(1,894)
Effect of exchange rate changes on cash	89	(285)
Increase (decrease) in cash and cash equivalents	(3,472)	20,234
Cash and cash equivalents at beginning of period	52,485	13,592
Cash and cash equivalents at beginning of period	49,013	33,826
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents at end of period	48,355	33,826
Restricted cash at end of period	658	0
Total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows	$ 49,013	$ 33,826